Cypress Capital Management LLC (WY)
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1633896
SHERIDAN, WY
Position in HALO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,870
+$1,023 QoQ
Shares Held
75
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#596
of 667 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cypress Capital Management LLC (WY) holds $81,675 across 3 Biotechnology names. HALO ranks #2 (7.2% of the industry book) .
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,870 | 75 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,847 | 75 | Shares | Sole | 2026-05-08 | |
| 2021-06-30 | $4,995 | 110 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,585 | 110 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $23,276 | 545 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||